Cargando…

The Clinical Manifestations and Chest Computed Tomography Findings of Coronavirus Disease 2019 (COVID-19) Patients in China: A Proportion Meta-Analysis

OBJECTIVES: The objectives of this study were to identify the clinical features and chest computed tomography (CT) findings of coronavirus disease 2019 (COVID-19) patients and to compare the characteristics of patients diagnosed in Wuhan and in other areas of China by integrating the findings report...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Joo-Hyun, Jang, Wook, Kim, Sang-Woo, Lee, Jeongjun, Lim, Yun-Sung, Cho, Chang-Gun, Park, Seok-Won, Kim, Bo Hae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Otorhinolaryngology-Head and Neck Surgery 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248616/
https://www.ncbi.nlm.nih.gov/pubmed/32434310
http://dx.doi.org/10.21053/ceo.2020.00570
_version_ 1783538414043267072
author Park, Joo-Hyun
Jang, Wook
Kim, Sang-Woo
Lee, Jeongjun
Lim, Yun-Sung
Cho, Chang-Gun
Park, Seok-Won
Kim, Bo Hae
author_facet Park, Joo-Hyun
Jang, Wook
Kim, Sang-Woo
Lee, Jeongjun
Lim, Yun-Sung
Cho, Chang-Gun
Park, Seok-Won
Kim, Bo Hae
author_sort Park, Joo-Hyun
collection PubMed
description OBJECTIVES: The objectives of this study were to identify the clinical features and chest computed tomography (CT) findings of coronavirus disease 2019 (COVID-19) patients and to compare the characteristics of patients diagnosed in Wuhan and in other areas of China by integrating the findings reported in previous studies. METHODS: We conducted a proportion meta-analysis to integrate the results of previous studies identified in online databases, and subsequently compared the overlapping of 95% confidence intervals (CIs) between locations of diagnosis. The heterogeneity of the results of the included studies was also demonstrated. RESULTS: Nine studies with level IV evidence were considered to be eligible for the meta-analysis, and a comparative analysis was only possible between patients diagnosed in Wuhan and outside of Wuhan in China. Fever (84.8%; 95% CI, 78.5% to 90.1%) was identified as the most common clinical manifestation in all COVID-19 patients, and signs of respiratory infection were also frequently present in these patients. When comparing the clinical features according to the location of diagnosis, fever and dyspnea were less frequent in patients diagnosed outside of Wuhan (fever: 78.1%; 95% CI, 73.2% to 82.7%; dyspnea: 3.80%; 95% CI, 0.13% to 12.22%) than in patients diagnosed in Wuhan (fever: 91.7%; 95% CI, 88.0% to 94.8%; dyspnea: 21.1%; 95% CI, 13.2% to 30.3%). The chest CT findings exhibited no significant differences between the groups. CONCLUSION: Fever was found to be the most common symptom in COVID-19, and respiratory infection signs were also commonly present. Fever and dyspnea were less frequently observed in the patients diagnosed outside of Wuhan, which should be considered in COVID-19 screening programs. These results may be attributable to the earlier diagnosis of the disease and the younger age of patients outside of Wuhan although further analysis is needed. The role of chest CT in COVID-19 diagnosis is inconclusive based on this study.
format Online
Article
Text
id pubmed-7248616
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Korean Society of Otorhinolaryngology-Head and Neck Surgery
record_format MEDLINE/PubMed
spelling pubmed-72486162020-06-05 The Clinical Manifestations and Chest Computed Tomography Findings of Coronavirus Disease 2019 (COVID-19) Patients in China: A Proportion Meta-Analysis Park, Joo-Hyun Jang, Wook Kim, Sang-Woo Lee, Jeongjun Lim, Yun-Sung Cho, Chang-Gun Park, Seok-Won Kim, Bo Hae Clin Exp Otorhinolaryngol Original Article OBJECTIVES: The objectives of this study were to identify the clinical features and chest computed tomography (CT) findings of coronavirus disease 2019 (COVID-19) patients and to compare the characteristics of patients diagnosed in Wuhan and in other areas of China by integrating the findings reported in previous studies. METHODS: We conducted a proportion meta-analysis to integrate the results of previous studies identified in online databases, and subsequently compared the overlapping of 95% confidence intervals (CIs) between locations of diagnosis. The heterogeneity of the results of the included studies was also demonstrated. RESULTS: Nine studies with level IV evidence were considered to be eligible for the meta-analysis, and a comparative analysis was only possible between patients diagnosed in Wuhan and outside of Wuhan in China. Fever (84.8%; 95% CI, 78.5% to 90.1%) was identified as the most common clinical manifestation in all COVID-19 patients, and signs of respiratory infection were also frequently present in these patients. When comparing the clinical features according to the location of diagnosis, fever and dyspnea were less frequent in patients diagnosed outside of Wuhan (fever: 78.1%; 95% CI, 73.2% to 82.7%; dyspnea: 3.80%; 95% CI, 0.13% to 12.22%) than in patients diagnosed in Wuhan (fever: 91.7%; 95% CI, 88.0% to 94.8%; dyspnea: 21.1%; 95% CI, 13.2% to 30.3%). The chest CT findings exhibited no significant differences between the groups. CONCLUSION: Fever was found to be the most common symptom in COVID-19, and respiratory infection signs were also commonly present. Fever and dyspnea were less frequently observed in the patients diagnosed outside of Wuhan, which should be considered in COVID-19 screening programs. These results may be attributable to the earlier diagnosis of the disease and the younger age of patients outside of Wuhan although further analysis is needed. The role of chest CT in COVID-19 diagnosis is inconclusive based on this study. Korean Society of Otorhinolaryngology-Head and Neck Surgery 2020-05 2020-05-01 /pmc/articles/PMC7248616/ /pubmed/32434310 http://dx.doi.org/10.21053/ceo.2020.00570 Text en Copyright © 2020 by Korean Society of Otorhinolaryngology-Head and Neck Surgery This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Park, Joo-Hyun
Jang, Wook
Kim, Sang-Woo
Lee, Jeongjun
Lim, Yun-Sung
Cho, Chang-Gun
Park, Seok-Won
Kim, Bo Hae
The Clinical Manifestations and Chest Computed Tomography Findings of Coronavirus Disease 2019 (COVID-19) Patients in China: A Proportion Meta-Analysis
title The Clinical Manifestations and Chest Computed Tomography Findings of Coronavirus Disease 2019 (COVID-19) Patients in China: A Proportion Meta-Analysis
title_full The Clinical Manifestations and Chest Computed Tomography Findings of Coronavirus Disease 2019 (COVID-19) Patients in China: A Proportion Meta-Analysis
title_fullStr The Clinical Manifestations and Chest Computed Tomography Findings of Coronavirus Disease 2019 (COVID-19) Patients in China: A Proportion Meta-Analysis
title_full_unstemmed The Clinical Manifestations and Chest Computed Tomography Findings of Coronavirus Disease 2019 (COVID-19) Patients in China: A Proportion Meta-Analysis
title_short The Clinical Manifestations and Chest Computed Tomography Findings of Coronavirus Disease 2019 (COVID-19) Patients in China: A Proportion Meta-Analysis
title_sort clinical manifestations and chest computed tomography findings of coronavirus disease 2019 (covid-19) patients in china: a proportion meta-analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248616/
https://www.ncbi.nlm.nih.gov/pubmed/32434310
http://dx.doi.org/10.21053/ceo.2020.00570
work_keys_str_mv AT parkjoohyun theclinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT jangwook theclinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT kimsangwoo theclinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT leejeongjun theclinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT limyunsung theclinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT chochanggun theclinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT parkseokwon theclinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT kimbohae theclinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT parkjoohyun clinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT jangwook clinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT kimsangwoo clinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT leejeongjun clinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT limyunsung clinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT chochanggun clinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT parkseokwon clinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis
AT kimbohae clinicalmanifestationsandchestcomputedtomographyfindingsofcoronavirusdisease2019covid19patientsinchinaaproportionmetaanalysis